Proactive Investors - Run By Investors For Investors

Proactive news summary: Acal, Collagen Solutions, Europa Oil & Gas, Motive Television and more.

Motive Television faces market suspension, Tekcapital sees board member resign and big news for Europa.
The round up of the day's news

Motive Television (LON:MTV) warned it will be forced to suspend its AIM-listed shares on Monday unless it can find a replacement nomad.

Tekcapital (LON:TEK) non-executive Carl Nisser is stepping down from the board with immediate effect.

"We are thankful for Carl's participation and contribution to our business and wish him good fortune in all of his future endeavours," said: Clifford Gross, executive chairman.

Lender S&U’s (LON:SUS) motor finance business continues to grow, with customer numbers now up over 32% compared to the same time last year.

In the mining sector, North River Resources (LON:NRRP) said current drilling at its flagship Namib lead-zinc project had increased its confidence in the mineral resource at the Namibia property.

The group has drilled out 4,828 metres since the last estimate was published in 2014.

Additionally, small-cap oiler Europa Oil & Gas (LON:EOG) has been awarded acreage in Ireland’s Atlantic margins, securing one licence option.

Europa was the only small cap among several major international oil and gas companies to have been awarded new exploration acreage.

In other news, analytics software provider StatPro (LON:SOG) is to take a 51% stake in South Africa-based InfoVest Consulting, a software specialist for fund managers.

The deal is expected to be earnings enhancing in 2016.

Customised electronics supplier Acal (LON:ACL), announced the acquisition of Canada-based Plitron for £2mln. It is also set to hit its earnings forecast this year.

And finally, medical grade collagen manufacturer Collagen Solutions (LON:COS) today announced the death of its scientific adviser Professor Robert Brown, following a short illness.

Professor Brown of the University College London was a leading expert in the field of tissue engineering and collagen chemistry.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use